Does CEMIPLIMAB Cause Disease progression? 30 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Disease progression have been filed in association with CEMIPLIMAB (LIBTAYO). This represents 2.9% of all adverse event reports for CEMIPLIMAB.
30
Reports of Disease progression with CEMIPLIMAB
2.9%
of all CEMIPLIMAB reports
11
Deaths
11
Hospitalizations
How Dangerous Is Disease progression From CEMIPLIMAB?
Of the 30 reports, 11 (36.7%) resulted in death, 11 (36.7%) required hospitalization, and 1 (3.3%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for CEMIPLIMAB.
What Other Side Effects Does CEMIPLIMAB Cause?
Fatigue (68)
Pyrexia (49)
Pneumonia (41)
Dyspnoea (40)
Pneumonitis (38)
Off label use (35)
Diarrhoea (34)
Rash (34)
Cytokine release syndrome (33)
Pain (33)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which CEMIPLIMAB Alternatives Have Lower Disease progression Risk?
CEMIPLIMAB vs CEMIPLIMAB-RWLC
CEMIPLIMAB vs CENEGERMIN-BKBJ
CEMIPLIMAB vs CENOBAMATE
CEMIPLIMAB vs CEPHALEXIN
CEMIPLIMAB vs CERITINIB